Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov enrollment closed small index

Desaturation of Blood clinical trials

A small indexed set (2 trials) with no open enrollment listed right now.

Corpus placement: #7,188 of 28,707 conditions by registered trial count.

2 US clinical trials · none currently recruiting · #7,188 of 28,707 conditions by registered trial count

Desaturation of Blood: 2 US clinical trials tracked, none currently recruiting.

Desaturation of Blood is the subject of 2 registered US clinical trials on ClinicalTrials.gov, none currently recruiting. The most active sponsor is Medtronic - MITG, running 1 of these trials.

Enrollment posture brief

Registry condition desaturation-of-blood

OPEN 0 | RECR 0% | LATE 0 | EARLY 0 | RANK #7188 | SPON 1

Nearest open-share peer: Accelerated Phase Chronic Myelogenous Leukemia (0% recruiting · 12 trials)

Ablation80%ACL Reconstruction80%Abuse, Drug60%Acceptability60%Desaturation of Blood (this)0%
Open-enrollment share among volume-matched conditions near Desaturation of Blood

Desaturation of Blood has no open enrollment in this registry pull (2 archived studies). Peers show how other volume-matched labels compare on open share. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Desaturation of Blood on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Desaturation of Blood is recruiting below its size-band peers.

    0 of 2 indexed trials (0%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

Phase Distribution

Phase data not available

Top Sponsors

Named interventions

Most-linked intervention names on Desaturation of Blood records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Targeting SpO2 at 90-92% Other
1 trials
Targeting SpO2 at 93-95% Other
1 trials
Introduction of Motion conditions: tapping or rubbing Other
1 trials
Non-Invasive Controlled Hypoxia Device
1 trials

US sites by state

Facility locations filed on Desaturation of Blood trials. A trial with sites in several states counts in each.

Florida 1 trials
Colorado 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Desaturation of Blood page

2 registered trials, 0 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

  • No Desaturation of Blood trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Medtronic - MITG sponsors the most Desaturation of Blood trials on record, review their full trial history before evaluating a specific study. See Medtronic - MITG's trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Desaturation of Blood condition card totals 2 registered trials; most-linked intervention Targeting SpO2 at 90-92%; top US site state Florida. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.